Olympian Clinical Research

OCTOBER 14, 2021

If you’re thinking about joining a clinical trial, there are many benefits you could look forward to. But how can you tell if clinical trials are right for you? We’ve outlined five reasons why joining a clinical trial might be in your best interest. You’re Helping to Advance Medical Knowledge.

Clinical Trials 52

Clinical Trials Trials Doctors Therapies 52

biobide

FEBRUARY 2, 2024

Children and adolescents lack robust preclinical models to replicate the pathologies and provide precise and targeted therapies. This is why not many Pharma companies specifically specialize in discovering and developing pediatric cancer treatments; a great example of advancing new therapies for childhood cancer is the biotech Oncoheroes.

Disease 59

Disease Medical Schools Pharma Companies Clinical Trials 59

KIF1A

MAY 29, 2024

They prepared for this first dose with numerous assessments and evaluations, including a neurological exam, overnight EEG, cognitive evaluation, physical therapy assessment, blood work, and data collection using a movement monitor. On the day of the treatment, they checked into the hospital where Sloane was administered sedation medication.

Treatment 52

Treatment Doctors Hospitals Therapies 52

Alta Sciences

JUNE 27, 2023

Cancer Treatments, Clinical Trials, and the Motivation to Innovate nbartlett Tue, 06/27/2023 - 20:58 Getting to the Heart of Science with Michelle Newby At the heart of science are stories—stories of courage, challenges, successes, lessons, and people. A: I went with the clinical trial. A: I wouldn’t be here without clinical trials.

Clinical Trials 40

Clinical Trials Trials Treatment Doctors 40

Drug Target Review

JANUARY 23, 2024

Cell-based therapies, such as tumour-infiltrating lymphocyte (TIL) therapy, have also drawn significant attention following promising results in a melanoma trial. About the author Dr Espen Basmo Ellingsen University of Oslo Dr Ellingsen is a Medical Doctor and holds a PhD in cancer immunology from the University of Oslo.

Treatment 122

Treatment Immune Response Vaccine Therapies 122

The Pharma Data

JANUARY 17, 2021

The treatment could be administered in primary care centers to people who test positive for COVID-19, avoiding hospitalization due to the progression of the disease and complementing the vaccine in the early phase after vaccination. BARCELONA, Spain , Jan. 18, 2021 /PRNewswire/ — Grifols (MCE: GRF, MCE: GRF.P,

Clinical Trials 52

Clinical Trials Treatment Trials Hospitals 52

On Medicine

MAY 11, 2023

There are a few (but growing) centers that will proactively see patients with diabetes in high-risk areas when admitted to the hospital, however, by far the most common practice is for patients to only be seen by a specialist team, including for diabetes, on receipt of a referral.

Nurses 52

Nurses Research Doctors Hospitals 52

The Pharma Data

JANUARY 15, 2021

15, 2021 — An inhaled medication might make every day physical activity a bit easier for patients with serious scarring of the lungs, a new clinical trial finds. Right now, no medication is approved specifically for pulmonary hypertension caused by ILD, said Dr. Steven Nathan, senior researcher on the new trial. FRIDAY, Jan.

Disease 52

Disease Doctors FDA Approval Trials 52

Drug Discovery World

APRIL 14, 2023

He is being recognised for his revolutionary contributions to developing the first gene-edited cell-based therapy for cancer that involves the genetic re-engineering of a patient’s own T cells to combat their disease, and for demonstrating that adoptive T-cell therapy can induce remission and in some cases cure patients with advanced cancer.

Clinical Trials 130

Clinical Trials Research Science Clinical Research 130

The Pharma Data

JANUARY 21, 2021

For one, the patients were not part of a clinical trial that directly tested stem cell transplants against standard MS medications. It requires a long hospital stay, plus a period of months when patients are severely immunocompromised, Bebo said. They all underwent transplants at various Italian medical centers between 1997 and 2019.

Therapies 52

Therapies Clinical Trials Doctors Trials 52

Codon

JANUARY 21, 2024

Human challenge trials were an indispensable part of the development of the malaria vaccine, R21/Matrix-M, endorsed by the World Health Organization last October. But for all of their benefits, human challenge trials have their drawbacks. Jake himself has participated in both Zika and Shigella challenge trials.

Vaccine 111

Vaccine Trials Disease Virus 111

The Pharma Data

NOVEMBER 17, 2020

17, 2020 — A procedure that freezes bits of heart tissue may be a better option than medication for people with atrial fibrillation (a-fib, or AF), two clinical trials have found. The two new trials challenged the notion that ablation should only be a second option. TUESDAY, Nov. It included 203 U.S.

Doctors 52

Doctors Trials Clinical Trials Treatment 52

Drug Discovery World

OCTOBER 18, 2022

For example, the University of Basel works very closely with partners from both the academic world and industry, and in 1996, it jointly founded the Neuroscience Network Basel along with the University Hospital, the Friedrich Miescher Institute and the local pharmaceutical industry.

International 130

International Engineering Science Pharmaceuticals 130

The Pharma Data

FEBRUARY 12, 2022

Doctors call this drug ‘bari,’ and receiving the pill once a day for up to 14 days yielded one of the largest a survival advantages seen yet in the COVID pandemic, according to a study published in The Lancet Respiratory Medicine. Source link: [link].

Hospitals 40

Hospitals Clinical Trials Licensing Licensing 40

The Pharma Data

JANUARY 20, 2021

The approval of Verquvo by the FDA, which is the first treatment for chronic heart failure approved specifically for patients following a hospitalization for heart failure or need for outpatient IV diuretics, is based on the results of the pivotal Phase 3 VICTORIA trial and follows a priority regulatory review. 0.98; p=0.019).

FDA Approval 52

FDA Approval FDA Hospitals Treatment 52

The Pharma Data

OCTOBER 19, 2020

Testing Therapies, Antivirals and Vaccines. There has been some discussion of running challenge trials for COVID-19 vaccines. In a challenge trial, people are given a vaccine then intentionally dosed with the virus or bacteria that causes the disease. But the UK is going to go ahead and try it anyway. Please read more here. .

Vaccine 52

Vaccine Virus FDA Clinical Trials 52

Codon

FEBRUARY 13, 2024

Tom Ireland writes about the companies and technologies that are reimagining phage therapy. Soon after its publication, scientists, journalists, and investors were revisiting ‘phage therapy’ as a promising alternative to our failing antibiotics. Read it on our website here. Illustration by David S. Fast forward to 2023.

Therapies 118

Therapies Virus DNA Clinical Trials 118

The Pharma Data

JULY 22, 2021

Treatment with ADUHELM should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials. Continued approval for this indication may be contingent upon verification of clinical benefit in confirmatory trial(s). Biogen Inc.

Disease 52

Disease Research Clinical Trials FDA 52

The Pharma Data

AUGUST 3, 2021

A recent trial showed a significantly lower risk with empagliflozin of hospitalization for heart failure or cardiovascular death in adult patients with HFpEF. Progress in mental health pipeline Boehringer Ingelheim also made progress in the area of neuropsychiatric disorders, including two ongoing phase II trials.

Research 52

Research Clinical Trials Treatment Production 52

The Pharma Data

MAY 15, 2021

If You or Someone You Love is Suffering From Chronic Fatigue Syndrome, Then This Will Be the Most Important Letter You Will Ever Read… “Doctors Told Me There Was No Cure For Chronic Fatigue Syndrome…But Contrary To Their Prediction, I Got My Life Back From My CFS…100% Naturally! Description: ATTENTION!

Doctors 52

Doctors Production Therapies Treatment 52

The Pharma Data

JULY 21, 2021

mg, 5 mg, and 10 mg) is indicated for the treatment of symptomatic chronic heart failure in adult patients with reduced ejection fraction who are stabilized after a recent decompensation event requiring intravenous (IV) therapy. In the EU, VERQUVO (2.5 VERQUVO is being jointly developed by Merck and Bayer AG. In January of this year, the U.S.

Treatment 52

Treatment Production Hospitals FDA Approval 52

The Pharma Data

JULY 8, 2021

When added to the EMPEROR-Reduced trial results, these findings demonstrate Jardiance’s efficacy in all forms of heart failure regardless of ejection fraction. Heart failure is a leading cause of hospitalization and is becoming increasingly prevalent in Western countries due to aging populations.

Trials 52

Trials Doctors Hospitals Clinical Trials 52

The Pharma Data

DECEMBER 20, 2020

Cefepime/enmetazobactam will be a welcome addition to the tools that doctors have to help their patients, and we look forward to introducing this antibiotic to hospitals and achieving a win-win collaboration.”. Cefepime/enmetazobactam has been granted Qualified Infectious Disease Product and Fast Track designation by the U.S.

Licensing 40

Licensing Licensing Pharmaceuticals Pharmaceutical Companies 40

The Pharma Data

JUNE 28, 2021

After seeing a doctor, he was diagnosed with plaque psoriasis—a chronic autoimmune disease that appears on the surface of the skin as raised, red, itchy patches, but actually starts inside the body, caused by dysfunction of the immune system. In some cases, patients were hospitalized.

Clinical Trials 52

Clinical Trials Treatment Trials Disease 52

Drug Target Review

SEPTEMBER 6, 2024

What trends are driving the increased use of in vivo delivery methods in gene therapy? Finally, the market demand has increased as clinical trials are advancing towards more advanced phases and more vectors are being approved for commercial use. How are new therapeutic areas emerging as potential targets for in vivo gene therapy?

Therapies 59

Therapies Vaccine Marketing Pharmacy 59

On Medicine

FEBRUARY 26, 2023

After many trials, and misdirection to the sexual health clinic, at the age of twenty-three, Daniella was finally diagnosed with Behçet’s disease. In addition to meaningful specialized treatment, Daniella uses her creative pursuits as a form of therapy, inspiring others living with chronic health issues through the use of her podcast.

Disease 40

Disease Nurses Treatment Doctors 40

The Pharma Data

JANUARY 26, 2021

percent) in patients taking therapy and 36 events (7.0 Bamlanivimab and etesevimab together also demonstrated statistically significant improvements on all key secondary endpoints, providing strong evidence that the therapy reduced viral load and accelerated symptom resolution. INDIANAPOLIS, Jan. have reached record highs.

Hospitals 52

Hospitals Treatment Long-Term Care Facilities Trials 52

Codon

JULY 14, 2024

While this departs from the reductionist, single-component therapies that have dominated transfusion medicine since World War II, emerging data underscores that whole blood transfusions—blood with all its parts—yield better outcomes following severe blood loss than transfusions involving discrete blood components. Always free.

Production 133

Production Clinical Trials Trials Therapies 133

Broad Institute

JANUARY 30, 2024

I’d seen more than my share of doctors by the time I graduated high school, but it gave me a lot of respect for them,” he said. “I For his medical residency, he moved to Massachusetts General Hospital, where he was enthralled with seeing patients, especially the ones with perplexing infections.

Hospitals 137

Hospitals Medical Schools Virus Science 137

The Pharma Data

NOVEMBER 4, 2020

Reaffirmed c linical trial results from study of VASCEPA in China are expected by year end 2020 : Assuming positive results from this study conducted by Amarin’s commercial partner for VASCEPA in China, regulatory submission in China could follow promptly thereafter. 2 Significant cardiovascular risk remains after statin therapy.

Production 40

Production FDA Trials Licensing 40

The Pharma Data

JUNE 26, 2021

Current guidelines are limited and recommend treating pediatric patients with or at risk for reoccurring blood clots with standard anticoagulant therapy, which often requires painful injections, dietary restrictions and regular laboratory monitoring. EINSTEIN-Jr is the largest pediatric study completed to date for the treatment of VTE.

Doctors 52

Doctors Hospitals Clinical Trials Treatment 52

The Pharma Data

NOVEMBER 10, 2020

As the new coronavirus continues raging through the global, however, many hopeful treatments for COVID-19, such as Remdesivir, Hydroxychloroquine, Lopinavir and Interferon regimens have been proven by WHO SOLIDARITY to have little or no effect on hospitalized COVID-19 patients. SHANGHAI , Nov. The paper has been contributed and under review.

Hospitals 52

Hospitals Clinical Trials Treatment Therapies 52

The Pharma Data

NOVEMBER 9, 2020

Bamlanivimab is authorized for the treatment of mild to moderate COVID-19 in adults and pediatric patients 12 years and older with a positive COVID-19 test, who are at high risk for progressing to severe COVID-19 and/or hospitalization. Patients treated with bamlanivimab showed reduced viral load and rates of symptoms and hospitalization.

Treatment 52

Treatment FDA Hospitals Long-Term Care Facilities 52

Codon

APRIL 9, 2024

After four years of a national effort to “ scientize Chinese medicine ” ( zhongyi kexuehua ), which designated Chinese doctors to study Western biomedicine, Mao Zedong reversed course in 1954, setting a new priority of “ Western doctors study Chinese medicine ( xiyi xuexi zhongyi ).”

Drugs 129

Drugs Science Research Doctors 129

Broad Institute

MAY 2, 2024

In 2021, Martin competed in the US Olympic trials in a lightweight double, and won the world-renowned Head of the Charles regatta in lightweight single sculls. In undergrad, I thought about going to medical school, but I didn’t want to work in a hospital. When your code runs perfectly or you fix a bug, it feels very rewarding.

Science 124

Science Medical Schools Hospitals Disease 124

The Pharma Data

MAY 13, 2021

In this special report, I’m going to show you why researchers at Harvard University and the Massachusetts General Hospital in Boston are now praising a strange new pain treatment originally discovered on the International Space Station. WITHOUT doctors, physical therapists or chiropractors. And then got my Doctor of Pharmacy (Pharm.

Pharmacy 52

Pharmacy Doctors Production Therapies 52

The Pharma Data

JUNE 18, 2021

“Combining our novel therapies to deliver a new potential treatment is an example of AbbVie’s innovative approach to identify options for difficult-to-treat blood cancers, like CLL,” said Mohamed Zaki , M.D., IMBRUVICA has been granted four Breakthrough Therapy Designations from the U.S.

Treatment 40

Treatment FDA FDA Approval Therapies 40